New flu shot for seniors enters first human safety tests

NCT ID NCT07302256

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: Shanghai Institute Of Biological Products Source: ClinicalTrials.gov ↗

Summary

This study is testing the safety and immune response of a new influenza (flu) vaccine in healthy adults aged 60 and older. It will enroll 120 participants to receive either the new vaccine, an existing vaccine, or a placebo shot. The main goal is to see how safe the new vaccine is and if it triggers a good immune response against the flu virus.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Danjiangkou Disease Prevention and Control Center
RECRUITING

Wuhan, Hubei, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INFLUENZA